Schwartz, Lisa M <br/><br/>
Randomized Study of Providing Evidence Context to Mitigate Physician Misinterpretation Arising From Off-Label Drug Promotion.  [electronic resource] 

 -  Circulation. Cardiovascular quality and outcomes  11 2019 
 - e006073 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1941-7705 
<br/><br/><label>Standard No.: </label>10.1161/CIRCOUTCOMES.119.006073  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Advertising<br/>Attitude of Health Personnel<br/>Cardiovascular Diseases--diagnosis<br/>Clinical Decision-Making<br/>Drug Labeling<br/>Education, Medical, Continuing<br/>Fatty Acids, Omega-3--adverse effects<br/>Female<br/>Health Knowledge, Attitudes, Practice<br/>Humans<br/>Hypertriglyceridemia--blood<br/>Hypolipidemic Agents--adverse effects<br/>Male<br/>Marketing of Health Services<br/>Middle Aged<br/>Off-Label Use<br/>Patient Safety<br/>Patient Selection<br/>Physicians--psychology<br/>Practice Patterns, Physicians'<br/>Risk Assessment<br/>Risk Factors<br/>United States<br/>United States Food and Drug Administration